Vault-13

Sarissa Capital Management LP

GREENWICH, CT · CIK 1577524 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$993.5m reported value -6.1% vs Q1 2022
11positions
100.0%in top 10
1 new 0 added 3 reduced 1 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALKERMES PLC SHS ALKS ALKS 14,040,000 $418.3m42.10% 42.10% UnchangedShares held: Q3 2021 13.2m, Q4 2021 14.0m, Q1 2022 14.0m, Q2 2022 14.0m
2 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 16,390,000 $189.0m19.02% 19.02% UnchangedShares held: Q3 2021 16.4m, Q4 2021 16.4m, Q1 2022 16.4m, Q2 2022 16.4m
3 BIOGEN INC COM BIIB BIIB 643,000 $131.1m13.20% 13.20% UnchangedShares held: Q3 2021 643.0k, Q4 2021 643.0k, Q1 2022 643.0k, Q2 2022 643.0k
4 INNOVIVA INC COM INVA INVA 6,614,000 $97.6m9.83% 9.83% UnchangedShares held: Q3 2021 6.6m, Q4 2021 6.6m, Q1 2022 6.6m, Q2 2022 6.6m
5 GILEAD SCIENCES INC COM GILD GILD 1,341,900 $82.9m8.35% 8.35% ReducedShares held: Q3 2021 3.0m, Q4 2021 2.9m, Q1 2022 1.6m, Q2 2022 1.3m -221.0k -221,000 -14.1%
6 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 23,998,000 $35.8m3.60% 3.60% ReducedShares held: Q3 2021 8.5m, Q4 2021 19.2m, Q1 2022 24.0m, Q2 2022 24.0m -2.0k -2,000 -0.0%
7 MERSANA THERAPEUTICS INC COM COM 4,299,297 $19.9m2.00% 2.00% UnchangedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 4.3m, Q2 2022 4.3m
8 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,390,790 $14.7m1.48% 1.48% UnchangedShares held: Q3 2021 3.9m, Q4 2021 4.0m, Q1 2022 1.4m, Q2 2022 1.4m
9 VOR BIOPHARMA INC COM COM 618,000 $3.1m0.31% 0.31% ReducedShares held: Q3 2021 707.0k, Q4 2021 707.0k, Q1 2022 707.0k, Q2 2022 618.0k -89.0k -89,010 -12.6%
10 PEAR THERAPEUTICS INC CLASS A COM CLASS A COM 500,356 $771.0k0.08% 0.08% UnchangedShares held: Q3 2021 0, Q4 2021 500.4k, Q1 2022 500.4k, Q2 2022 500.4k
11 REGULUS THERAPEUTICS INC COM RGLS RGLS 185,183 $383.0k0.04% 0.04% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 185.2k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
REGULUS THERAPEUTICS INC RGLS RGLS 1,851,851 $552.0k1.9m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
AMARIN CORP PLC 13D · filed 2026-08-27 6.1% -2.0 pts 13D 2026-08-27
IRONWOOD PHARMACEUTICALS INC IRWD · 13D · filed 2026-03-19 IRWD 5.8%≈ $39.8m 13D 2026-03-19